"Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From" by Robert Feldman

Menu

Skip to main content

All Publications

Robert Feldman, Baptist Health Medical GroupFollow

Elagolix Suppresses Ovulation in a Dose-Dependent Manner: Results From a 3-Month, Randomized Study in Ovulatory Women

Publication Date

2020

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Journal of Clinical Endocrinology and Metabolism (2020) 105(3):dgz086

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS